Midway through 2025 I have some good news to share. We are starting to see positive market trends. Trends that I believe will continue to improve the Medical Technologies Labor Market.
Personally, I have had a slow and steady desk in 2025, which dates back to Labor Day 2024, when I have consistently had a number of job openings across Engineering, Market Access, Sales, and Marketing in Medical Technologies. This is not unique to me, as my HCRI colleagues are experiencing a similar year.
Another trend I am experiencing is that all the candidates I have out interviewing are also interviewing with other companies. I am even dealing with more competing offers than before. This points to more opportunities in Medical Technologies, especially for those with the desired industry skill sets.
The underlying mechanics of the job market improvement are the continued increase in financial transactions for both funding and acquisitions from 2023 to 2024, with the first half of 2025 being even better. Let’s take a look at the data available to reinforce what we’re feeling every day.
MedTech VC Funding Trends Over Time
We see massive increases in VC funding in recent years, moving from about $13.1 billion in 2020 up to roughly $4.1 billion in Q1 alone in 2025. Here’s where analysts see the sources of recent fluctuation coming from:
- 2020–2021 Boom: Fueled by pandemic urgency, telehealth, and diagnostics. 2022–2023 Dip: Interest rate hikes and investor caution led to fewer mega-rounds.
- 2024–2025 Recovery: AI, whole-body screening, and smart diagnostics are driving renewed investor confidence.
Annual MedTech VC Funding Comparison
When we look back further, to 2015, the scale of change is even more poignant.
Chart data sources: JPMorgan.com; MedTechDive.com
Footnotes: * 2024 data is an estimate; ** 2025 data is an extremely rough estimate. It was created by multiplying Q1 2025 VC funding by 4.
A few other recent nuggets to consider:
- Q1 2025: $4.1 billion Medtech VC funding across 216 deals — the highest since 2022
- Q1 2024: Roughly $3.7 billion invested in 117 deals — indicating strong deal velocity but fewer rounds
- Q2 2025 vs Q2 2024: ~10% in funding, ~28% in deals.
How are Medtech Acquisitions Looking?
In Q1 2025, I tracked 57 MedTech M&A transactions—just a slight dip from the 62 deals we saw in Q4 2024. But what really caught my attention wasn’t the volume—it was the value. Deal totals surged to approximately $9.2 billion, a dramatic jump from $2.7 billion the previous quarter.
This shift tells me something important: buyers aren’t just chasing volume—they’re making bigger, more strategic bets. According to J.P. Morgan’s Q1 2025 MedTech report, this quarter saw a clear pivot toward high-value acquisitions. It reflects a growing appetite for companies with mature pipelines, commercial traction, or differentiated technologies.
We’re also seeing a trend toward precision dealmaking. Rather than broad asset aggregation, buyers are targeting platforms that align with their core growth priorities—especially in areas like AI-powered diagnostics, surgical innovation, and real-world data analytics. Stryker’s $4.9 billion acquisition of Inari Medical is a prime example, expanding its footprint in cardiovascular care while integrating procedural intelligence and AI-assisted technologies.
What does this mean for the rest of 2025? I expect this momentum to continue, especially as strategic buyers and private equity sponsors double down on innovation-led acquisitions. It’s worth paying attention to how deal value is outpacing deal count. The market is rewarding clarity, focus, and long-term vision. These increases in deal volume will continue to improve the MedTech Labor Market.
Capitalize on a Medtech Strong Market
If you’re a MedTech professional thinking about your next chapter—or a hiring leader looking to tap into this moment of momentum—I’d welcome a conversation. The opportunities unfolding in our space aren’t just market movements; they’re signs of real growth, collaboration, and innovation. Whether you’re exploring a new role or trying to find the right talent to take your team to the next level, let’s talk. I’m here to help you navigate the landscape and make the most of this promising time.
You can also connect with me on LinkedIn here.
Article Sources:
